Search Results - "Rybkin, Alisa"

Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation by Romesser, Paul B, Cahlon, Oren, Scher, Eli, Zhou, Ying, Berry, Sean L, Rybkin, Alisa, Sine, Kevin M, Tang, Shikui, Sherman, Eric J, Wong, Richard, Lee, Nancy Y

“…Abstract Background As proton beam radiation therapy (PBRT) may allow greater normal tissue sparing when compared with intensity-modulated radiation therapy…”
Get full text

Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer: Organ Preservation in T4 Throat Cancer by Eita, Amgad, Mohamed, Nader, Rybkin, Alisa, Kang, Jung Julie, Fiasconaro, Megan, Zhigang, Zhang, Zakeri, Kaveh, Yu, Yao, Sadaka, Emad, Sherman, Eric, Dunn, Lara, Cracchiolo, Jennifer, Wong, Richard J., Cohen, Marc, Lee, Nancy Y.

Get full text

Outcomes for Organ Preservation with Chemoradiation Therapy for T4 Larynx and Hypopharynx Cancer by Eita, Amgad, Mohamed, Nader, Rybkin, Alisa, Kang, Jung Julie, Fiasconaro, Megan, Zhigang, Zhang, Zakeri, Kaveh, Yu, Yao, Sadaka, Emad, Sherman, Eric, Dunn, Lara, Cracchiolo, Jennifer, Wong, Richard J., Cohen, Marc, Lee, Nancy Y.

“…Objective Limited data is available to guide non‐surgical management of Stage T4 larynx and hypopharynx cancer patients who have inoperable disease or refuse…”
Get full text

The 3 Bs of cancer care amid the COVID‐19 pandemic crisis: “Be safe, be smart, be kind”—A multidisciplinary approach increasing the use of radiation and embracing telemedicine for head and neck cancer by Kang, Jung Julie, Wong, Richard J., Sherman, Eric J., Rybkin, Alisa, McBride, Sean M., Riaz, Nadeem, Tsai, C. Jillian, Yu, Yao, Chen, Linda, Zakeri, Kaveh, Gelblum, Daphna Y., Gillespie, Erin F., Cohen, Marc A., Cracchiolo, Jennifer R., Ganly, Ian, Patel, Snehal, Singh, Bhuvanesh, Boyle, Jay O., Roman, Benjamin R., Morris, Luc G., Shaha, Ashok R., Dunn, Lara A., Ho, Alan L., Fetten, James V., Shah, Jatin P., Pfister, David G., Lee, Nancy Y.

“…Because of the national emergency triggered by the coronavirus disease 2019 (COVID‐19) pandemic, government‐mandated public health directives have drastically…”
Get full text

The effect of short radiation treatment breaks on chemo‐radiotherapy for oropharyngeal cancers by Rybkin, Alisa, Kang, Jung Julie, Lee, Anna, Kitpanit, Sarin, Fan, Ming, Mohamed, Nader, Cartano, Olivia, Zakeri, Kaveh, Gelblum, Daphna, Sherman, Eric, Dunn, Lara, Boyle, Jay, Wong, Richard, Chen, Linda, Yu, Yao, McBride, Sean M., Tsai, C. Jillian, Riaz, Nadeem, Lee, Nancy Y.

“…Background Numerous studies and guidelines suggest an outcome detriment from radiation treatment breaks (rTBs) and the need for compensatory dosing in patients…”
Get full text

Any day, split halfway: Flexibility in scheduling high‐dose cisplatin—A large retrospective review from a high‐volume cancer center by Kang, Jung Julie, Tchekmedyian, Vatche, Mohammed, Nader, Rybkin, Alisa, Kitpanit, Sarin, Fan, Ming, Wang, Huili, Lobaugh, Stephanie M., Zhang, Zhigang, Lee, Anna, Chen, Linda, Yu, Yao, Zakeri, Kaveh, Gelblum, Daphna Y., Riaz, Nadeem, McBride, Sean M., Tsai, C. Jillian, Cohen, Marc A., Cracchiolo, Jennifer R., Morris, Luc G., Singh, Bhuvanesh, Patel, Snehal, Ganly, Ian, Boyle, Jay O., Wong, Richard J., Eng, Juliana, Zhi, Wanqing Iris, Ng, Kenneth, Ho, Alan L., Dunn, Lara A., Michel, Loren, Fetten, James V., Pfister, David G., Lee, Nancy Y., Sherman, Eric J.

“…High‐dose (HD) cisplatin remains the standard of care with chemoradiation for locally advanced oropharyngeal cancer (OPC). Cooperative group trials mandate…”
Get full text